Cleared Abbreviated

K231575 - Vecttor VT-300

K231575 is an FDA 510(k) clearance for Vecttor VT-300, manufactured by Artaflex, Inc.. The device is a Class 2 Neurology device with product code LIH cleared through the Abbreviated 510(k) pathway after a 253-day FDA review.

K231575 · Artaflex, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2024
Decision
253d
Days
Class 2
Risk

K231575 is an FDA 510(k) clearance for the Vecttor VT-300. Classified as Interferential Current Therapy (product code LIH), Class II - Special Controls.

Submitted by Artaflex, Inc. (Markham, CA). The FDA issued a Cleared decision on February 8, 2024 after a review of 253 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Artaflex, Inc. devices

FDA 510(k) Submission Details - K231575

510(k) Number K231575 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 31, 2023
Decision Date February 08, 2024
Days to Decision 253 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
105d slower than avg
Panel avg: 148d · This submission: 253d
Pathway characteristics
Standards-based clearance path.

LIH Device Classification - Class 2, Special Controls

Product Code LIH Interferential Current Therapy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LIH Interferential Current Therapy

All 31
Devices cleared under the same product code (LIH) and FDA review panel - the closest regulatory comparables to K231575.
ETD4000
K202725 · Therasigma, LLC · Mar 2021
Avid IF2
K183692 · Vision Quest Industries Inc./Dba VQ Orthocare · Jun 2019
EVERYWAY INTERFERNTIAL STIMULATOR, MODEL IF-908
K110509 · Everyway Medical Instruments Co.,Ltd · Jun 2011
IF TRUE SINE INTERFERENTIAL STIMULATOR, WL-2206D
K092763 · Well-Life Healthcare Limited · Oct 2009
IF SERIES TRUE SINE INTERFERENTIAL STIMULATOR, MODEL: WL-2206B AND WL-2106E
K090023 · Well-Life Healthcare Limited · Jan 2009
INFINITY ELECTROTHERAPY SYSTEM
K042057 · Empi · Dec 2004